Where does Kymab Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Kymab Limited ranks #3,600 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Kymab Limited hold?

Kymab Limited holds 102 US utility patents granted between 2015 and 2025, spanning 13 technology areas.

What is Kymab Limited's Innovation Score?

Kymab Limited has an Innovation Score of 50.0 out of 100 (top 14% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Kymab Limited focus on?

Kymab Limited's top technology area is C07K (Peptides) with 99 patents. Grants appear in 13 CPC subclasses total.

Is Kymab Limited's patent grant rate increasing or decreasing?

Kymab Limited's recent grant velocity is -35% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Kymab Limited's patents?

Kymab Limited's patents average 20.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Kymab Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Kymab Limited

USPTO PatentsView assignee record - 102 granted patents across 13 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Kymab ranks #3,600 of 49,997 tracked US assignees by granted-patent volume, with 102 patents across 13 technology areas.

#3,600
of 49,997 US assignees by volume: Top 14%
by Innovation Score (50.0/100): 20.8
avg claims per patent: -35%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3600 · Foreign Corporation #3,600 · 102 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-MID 102 grants
TOP-DECILE #3,600/49,997
PHOTO-FINISH H C Starck
CPC-FOCUS C07K · 13 areas
INNOV-PAR 50.0/100
CLAIMS-DENSE 20.8 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -35% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: H.C. Starck Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Cardiovalve · near

50
Centripetal Networks · near

50
Kymab · this assignee

50
National Products · near

50
REIFENHÄUSER & KG… · near

50
3D Lighting… · lowest

7

What this shows Kymab's Innovation Score is 50.0/100 (top 14% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Kymab's grants concentrate

Kymab Limited is a focused PatentsView assignee: 13 CPC subclasses with 97.1% of grants classified under C07K (Peptides). Peak complete grant year is 2015 (23 grants) versus a trough of 3 in 2021. By volume, Kymab sits between H.C. Starck Inc. and Peking University Founder Group Co., Ltd..

Kymab's three-year grant acceleration

Kymab Limited shows 25 grants in 2022–2024 against only 19 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

H C Starck

102
Inficon

102
Infineum Internat…

102
Kakao

102
Mellanox TLV

102
Nisshin Steel

102
Ormco

102
Peking University…

102
Kymab ◀

102

What this shows Kymab holds 102 patents at rank #3,600, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Kymab

By rank, the assignees closest to #3,600 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Kymab's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Kymab, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (50 here).

Centripetal Networks, LLC 50 Cardiovalve Ltd. 50 REIFENHÄUSER GMBH & Co. KG Maschinenfabrik 50 National Products, Inc. 50

Similar claim depth

Nearest assignees by average claims per patent (20.8 here).

Infoblox Inc. 20.8 avg University of British Columbia 20.8 avg Debiotech S.A. 20.9 avg President and Fellows of Harvard College 20.8 avg

Kymab's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

50 Top 14% higher than 86% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Kymab Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	23	22.5%
2016	15	14.7%
2017	6	5.9%
2018	11	10.8%
2019	5	4.9%
2020	11	10.8%
2021	3	2.9%
2022	7	6.9%
2023	12	11.8%
2024	6	5.9%
2025partial year	3	2.9%

Which technologies does Kymab Limited patent most?

C07K - Peptides 99

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 62

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 36

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 32

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 32

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 29

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 11

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 8

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 4

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 4

C40B - Combinatorial CHEMISTRY; Libraries, e.g. Chemical Libraries 3

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 3

Y02A - Technologies FOR Adaptation TO Climate Change 2

Top 13 of 13 technology areas

Where it ranks

Overall rank by patents

#3,600

of 49,997 tracked assignees

Innovation Score

50.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Kymab Limited's patent record in context - here's where to go next.

Kymab Limited's lead technology class is C07K (Peptides), 97.1% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #3,600 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Kymab Limited against H.C. Starck Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 50.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.